ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ZEMPLAR INJECTION
Secondary hyperparathyroidism or hypocalcemia
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ZEMPLAR INJECTION Rx

Generic Name and Formulations:
Paricalcitol 2mcg/mL, 5mcg/mL; soln for IV inj; contains alcohol.

Company:
AbbVie

Therapeutic Use:

Indications for ZEMPLAR INJECTION:

Secondary hyperparathyroidism due to chronic kidney disease Stage 5.

Adults and Children:

Give as IV bolus inj during dialysis. ≥5yrs: Initially 0.04–0.1mcg/kg (2.8–7mcg) no more often than every other day; may increase in increments of 2–4mcg at 2–4 week intervals; max 0.24mcg/kg (16.8mcg). Titrate based on iPTH levels (see full labeling).

Contraindications:

Vit. D toxicity. Hypercalcemia.

Warnings/Precautions:

Risk of hypercalcemia. Monitor serum calcium, phosphorus, and iPTH at least every 2 weeks for 3 months after starting or dose changes, then monthly for 3 months, then every 3 months. If hypercalcemia or elevated Ca x P product occurs, reduce dose or stop until normal. Severe hepatic impairment. Pregnancy. Nursing mothers: not recommended.

Interactions:

Potentiated by potent CYP3A4 inhibitors (eg, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconazole); monitor and dose adjustment may be needed. Caps: cholestyramine or mineral oil may impair absorption; separate dosing by ≥1hr before or 4–6hrs after. Avoid concomitant Vit. D, phosphate, calcium-containing products, or thiazide diuretics. Caution with concomitant digitalis compounds; increased toxicity. Concomitant aluminum-containing preparations (eg, antacids, phosphate binder); may cause aluminum bone toxicity.

See Also:

ZEMPLAR CAPSULES

Pharmacological Class:

Vit. D analog.

Adverse Reactions:

Diarrhea, nasopharyngitis, dizziness, vomiting, hypertension, hypersensitivity, nausea, edema; hypercalcemia, hypercalciuria, hyperphosphatemia, suppression of PTH, adynamic bone disease.

Generic Availability:

YES

How Supplied:

Caps—30; Vial 2mcg (1mL), 5mcg (1mL, 2mL)—25

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs